Trial intelligence / Profile preview

Low-Intensity Neodymium Laser for Vaginal Atrophy

NCT05335317Recruiting

Sponsor
MeLSyTech
Start
Apr 2022
Primary completion
Sep 2025
Countries
1
01

Overview

Open-label trial (3 arms), sponsored by MeLSyTech. Primary endpoints: Vaginal Health Index, Periodic Acid Schiff Reaction Percentage and 1 more. Started Apr 2022; status: recruiting.

Beyond the preview

Go deeper on NCT05335317.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05335317.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call